C12N 2710/14144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/14144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 31 US grants and 74 published applications in this corpus.
Search patents in C12N- Granted patents
- 31
- Published applications
- 74
- Assignees
- 30
- Inventors
- 148
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 1 | 3 |
| 2014 | 0 | 2 |
| 2015 | 3 | 4 |
| 2016 | 2 | 0 |
| 2017 | 1 | 4 |
| 2018 | 3 | 5 |
| 2019 | 3 | 3 |
| 2020 | 4 | 6 |
| 2021 | 0 | 10 |
| 2022 | 3 | 6 |
| 2023 | 5 | 10 |
| 2024 | 0 | 12 |
| 2025 | 1 | 2 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Baculovirus expression system28 Jul 2026US 12,692,481 B2Virovek, Inc.
- AAV6 variants12 May 2026US 12,624,367 B2University of Florida Research Foundation, Inc.
- Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (rAAV) in insect cell10 Mar 2026US 12,571,001 B2Genevoyager (Wuhan) Co., Ltd.
- Preparation method and system for recombinant adeno-associated virus, and recombinant bacmid1 Jul 2025US 12,344,856 B2Genevoyager (Wuhan) Co., Ltd.
- Compositions and methods of treating Huntington's disease12 Sep 2023US 11,752,181 B2Voyager Therapeutics, Inc.
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
- Raav production in insect cells16 Apr 2026US 2026/0103729 A1Adverum Biotechnologies, Inc.
- Controlled expression of viral proteins26 Mar 2026US 2026/0085328 A1Voyager Therapeutics, Inc.
- Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (raav) in insect cell27 Feb 2025US 2025/0066814 A1Genevoyager (Wuhan) Co., Ltd.
- Recombinant adeno-associated virus (raav) genome and single-polarity raav vector packaged thereby20 Feb 2025US 2025/0059562 A1
Most cited
By later US patents
- AAV vectors produced in insect cells66US 8,163,543 B2Amsterdam Molecular Therapeutics B.V. · 2012
- Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV45US 8,512,981 B2Amsterdam Molecular Therapeutics B.V. · 2013
- Baculovirus dual promoter expression vector44US 5,169,784 AThe Texas A&M University System · 1992
- Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV18US 9,708,627 B2uniQure IP B.V. · 2017
- Viral vector for the targeted transfer of genes in the brain and spinal cord4US 10,287,318 B2Boehringer Ingelheim International GmbH · 2019